1 Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
2 Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
3 Department of Medicine, Harvard Medical School, Boston, Massachusetts.
4 Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
5 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.
This economic evaluation estimates the out-of-pocket cost savings patients could achieve if generic drugs were purchased directly from the Mark Cuban Cost Plus Drug Company rather than using their health insurance.